8 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... or those with clinical ... Two newer agents ... also effective agents ... #SSTIs #Algorithm
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
just simply a clinical ... range of possible clinical ... #differential #algorithm ... cardiology #treatment #table ... #foamed #heartfailure
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... event, follow ACC algorithm ... Change in clinical ... Stable patients ... postoperative cardiac events
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
This becomes a flawed ... are typically able ... #diagnosis #algorithm ... echocardiogram #management #clinical ... #criticalcare #foamed
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
This becomes a flawed ... are typically able ... management #cardiology #clinica ... l#foamed #algorithm
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... stable and no medical ... >7 days or • Clinically ... neutropenic #fever #IDSA ... #Algorithm #Management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... penetration • Variable bioavailability ... tolerable • Limited clinical ... antifungals #comparison #table